Trial Profile
Effects of Liraglutide on Cognition, Chronic Inflammation and Glycemic Control in Overweight and Obese, HIV-infected Subjects With Type 2 Diabetes.
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Feb 2020 Planned End Date changed from 1 May 2019 to 1 May 2020.
- 21 Feb 2020 Planned primary completion date changed from 1 Apr 2019 to 1 Apr 2020.
- 21 Feb 2020 Status changed from recruiting to suspended.